{"id":43294,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/asset-purchase-agreement-gilead-sciences-inc-and-osi.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"asset-purchase-agreement-gilead-sciences-inc-and-osi","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/asset-purchase-agreement-gilead-sciences-inc-and-osi.html","title":{"rendered":"Asset Purchase Agreement – Gilead Sciences Inc. and OSI Pharmaceuticals Inc."},"content":{"rendered":"
\n
\n
ASSET PURCHASE AGREEMENT<\/b><\/font><\/p>\n\n
between: <\/font><\/p>\n\n
GILEAD SCIENCES, INC.,
  <\/b><\/font>a Delaware corporation; <\/font><\/p>\n\n
and <\/font><\/p>\n\n
OSI PHARMACEUTICALS, INC.<\/b><\/font>,
 \na Delaware corporation <\/font><\/p>\n\n
\n
Dated \nas of November 26, 2001 <\/font><\/p>\n\n
\n
\n
\n
\n\n\n
 <\/a> <\/font> TABLE OF CONTENTS  <\/b><\/font><\/p>\n\n\n<\/pre>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1.<\/font><\/td>\n <\/font><\/td>\nSale and Purchase of Assets; Related Transactions<\/font><\/td>\n <\/font><\/td>\n1<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.1<\/font><\/td>\n <\/font><\/td>\nSale and Purchase of Assets<\/font><\/td>\n <\/font><\/td>\n1<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.2<\/font><\/td>\n <\/font><\/td>\nExcluded Assets<\/font><\/td>\n <\/font><\/td>\n1<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.3<\/font><\/td>\n <\/font><\/td>\nPurchase Price<\/font><\/td>\n <\/font><\/td>\n2<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.4<\/font><\/td>\n <\/font><\/td>\nSales and Transfer Taxes<\/font><\/td>\n <\/font><\/td>\n2<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.5<\/font><\/td>\n <\/font><\/td>\nAllocation of Purchase Price<\/font><\/td>\n <\/font><\/td>\n2<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.6<\/font><\/td>\n <\/font><\/td>\nAncillary Agreements<\/font><\/td>\n <\/font><\/td>\n3<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n1.7<\/font><\/td>\n <\/font><\/td>\nClosing<\/font><\/td>\n <\/font><\/td>\n4<\/font><\/td>\n<\/tr>\n

\n2.<\/font><\/td>\n
 <\/font><\/td>\n
\nRepresentations and Warranties of Seller<\/font><\/td>\n
 <\/font><\/td>\n
\n4<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.1<\/font><\/td>\n <\/font><\/td>\nTitle to Assets<\/font><\/td>\n <\/font><\/td>\n4<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.2<\/font><\/td>\n <\/font><\/td>\nSpecified Patents; Specified Know-How<\/font><\/td>\n <\/font><\/td>\n4<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.3<\/font><\/td>\n <\/font><\/td>\nSpecified Contracts; Real Property Leases; Equipment; Certain Materials<\/font><\/td>\n <\/font><\/td>\n5<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.4<\/font><\/td>\n <\/font><\/td>\nCompliance with Legal Requirements<\/font><\/td>\n <\/font><\/td>\n5<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.5<\/font><\/td>\n <\/font><\/td>\nRegulatory Matters<\/font><\/td>\n <\/font><\/td>\n6<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.6<\/font><\/td>\n <\/font><\/td>\nEmployee Matters<\/font><\/td>\n <\/font><\/td>\n7<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.7<\/font><\/td>\n <\/font><\/td>\nCertain Liabilities<\/font><\/td>\n <\/font><\/td>\n7<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.8<\/font><\/td>\n <\/font><\/td>\nLegal Proceedings<\/font><\/td>\n <\/font><\/td>\n7<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.9<\/font><\/td>\n <\/font><\/td>\nAuthority; Binding Nature of Agreement<\/font><\/td>\n <\/font><\/td>\n7<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.10<\/font><\/td>\n <\/font><\/td>\nNon-Contravention; Consents<\/font><\/td>\n <\/font><\/td>\n7<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n2.11<\/font><\/td>\n <\/font><\/td>\nAcquisition of Securities<\/font><\/td>\n <\/font><\/td>\n8<\/font><\/td>\n<\/tr>\n

\n3.<\/font><\/td>\n
 <\/font><\/td>\n
\nRepresentations and Warranties of Purchaser<\/font><\/td>\n
 <\/font><\/td>\n
\n8<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.1<\/font><\/td>\n <\/font><\/td>\nDue Organization<\/font><\/td>\n <\/font><\/td>\n8<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.2<\/font><\/td>\n <\/font><\/td>\nCapitalization<\/font><\/td>\n <\/font><\/td>\n8<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.3<\/font><\/td>\n <\/font><\/td>\nSEC Filings; Financial Statements<\/font><\/td>\n <\/font><\/td>\n8<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.4<\/font><\/td>\n <\/font><\/td>\nAbsence of Changes<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.5<\/font><\/td>\n <\/font><\/td>\nNo Undisclosed Liabilities<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.6<\/font><\/td>\n <\/font><\/td>\nNo Infringement<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.7<\/font><\/td>\n <\/font><\/td>\nCompliance with Legal Requirements<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.8<\/font><\/td>\n <\/font><\/td>\nLegal Proceedings<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.9<\/font><\/td>\n <\/font><\/td>\nAuthority; Binding Nature of Agreement<\/font><\/td>\n <\/font><\/td>\n9<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.10<\/font><\/td>\n <\/font><\/td>\nNon-Contravention; Consents<\/font><\/td>\n <\/font><\/td>\n10<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.11<\/font><\/td>\n <\/font><\/td>\nShares<\/font><\/td>\n <\/font><\/td>\n10<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n3.12<\/font><\/td>\n <\/font><\/td>\nFull Disclosure<\/font><\/td>\n <\/font><\/td>\n10<\/font><\/td>\n<\/tr>\n

\n4.<\/font><\/td>\n
 <\/font><\/td>\n
\nPre-Closing Covenants of Seller<\/font><\/td>\n
 <\/font><\/td>\n
\n10<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n4.1<\/font><\/td>\n <\/font><\/td>\nAccess<\/font><\/td>\n <\/font><\/td>\n10<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n4.2<\/font><\/td>\n <\/font><\/td>\nConduct of Business<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n4.3<\/font><\/td>\n <\/font><\/td>\nHSR Filing<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n4.4<\/font><\/td>\n <\/font><\/td>\nConsents<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n4.5<\/font><\/td>\n <\/font><\/td>\nConditions<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n

\n5.<\/font><\/td>\n
 <\/font><\/td>\n
\nPre-Closing Covenants of Purchaser<\/font><\/td>\n
 <\/font><\/td>\n
\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.1<\/font><\/td>\n <\/font><\/td>\nAccess<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.2<\/font><\/td>\n <\/font><\/td>\nHSR Filing<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.3<\/font><\/td>\n <\/font><\/td>\nSEC Reports<\/font><\/td>\n <\/font><\/td>\n11<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.4<\/font><\/td>\n <\/font><\/td>\nConsents; Releases<\/font><\/td>\n <\/font><\/td>\n12<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.5<\/font><\/td>\n <\/font><\/td>\nEmployment Matters<\/font><\/td>\n <\/font><\/td>\n12<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n5.6<\/font><\/td>\n <\/font><\/td>\nNasdaq Listing<\/font><\/td>\n <\/font><\/td>\n12<\/font><\/td>\n<\/tr>\n<\/table>\n
i<\/font><\/p>\n
\n
 <\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
 <\/font><\/td>\n <\/font><\/td>\n5.7<\/font><\/td>\n <\/font><\/td>\nConditions<\/font><\/td>\n <\/font><\/td>\n12<\/font><\/td>\n<\/tr>\n

\n6.<\/font><\/td>\n
 <\/font><\/td>\n
\nConditions Precedent to Purchaser’s Obligation to Close<\/font><\/td>\n
 <\/font><\/td>\n
\n12<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.1<\/font><\/td>\n <\/font><\/td>\nAccuracy of Representations<\/font><\/td>\n <\/font><\/td>\n12<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.2<\/font><\/td>\n <\/font><\/td>\nPerformance of Obligations<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.3<\/font><\/td>\n <\/font><\/td>\nHSR Act<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.4<\/font><\/td>\n <\/font><\/td>\nAdditional Documents<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.5<\/font><\/td>\n <\/font><\/td>\nNo Restraints<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n6.6<\/font><\/td>\n <\/font><\/td>\nConsents<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n

\n7.<\/font><\/td>\n
 <\/font><\/td>\n
\nConditions Precedent to Seller’s Obligation to Close<\/font><\/td>\n
 <\/font><\/td>\n
\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.1<\/font><\/td>\n <\/font><\/td>\nAccuracy of Representations<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.2<\/font><\/td>\n <\/font><\/td>\nPerformance of Obligations<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.3<\/font><\/td>\n <\/font><\/td>\nHSR Act<\/font><\/td>\n <\/font><\/td>\n13<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.4<\/font><\/td>\n <\/font><\/td>\nDelivery of Consideration<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.5<\/font><\/td>\n <\/font><\/td>\nAdditional Documents<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.6<\/font><\/td>\n <\/font><\/td>\nNo Restraints<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.7<\/font><\/td>\n <\/font><\/td>\nNasdaq Listing<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n7.8<\/font><\/td>\n <\/font><\/td>\nConsents<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n

\n8.<\/font><\/td>\n
 <\/font><\/td>\n
\nTermination<\/font><\/td>\n
 <\/font><\/td>\n
\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n8.1<\/font><\/td>\n <\/font><\/td>\nRight to Terminate Agreement<\/font><\/td>\n <\/font><\/td>\n14<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n8.2<\/font><\/td>\n <\/font><\/td>\nTermination Procedures<\/font><\/td>\n <\/font><\/td>\n15<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n8.3<\/font><\/td>\n <\/font><\/td>\nEffect of Termination<\/font><\/td>\n <\/font><\/td>\n15<\/font><\/td>\n<\/tr>\n

\n9.<\/font><\/td>\n
 <\/font><\/td>\n
\nIndemnification<\/font><\/td>\n
 <\/font><\/td>\n
\n15<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n9.1<\/font><\/td>\n <\/font><\/td>\nSurvival of Representations; Indemnification by Seller<\/font><\/td>\n <\/font><\/td>\n15<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n9.2<\/font><\/td>\n <\/font><\/td>\nIndemnification by Purchaser<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n

\n10.<\/font><\/td>\n
 <\/font><\/td>\n
\nMiscellaneous<\/font><\/td>\n
 <\/font><\/td>\n
\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.1<\/font><\/td>\n <\/font><\/td>\nTime of Essence<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.2<\/font><\/td>\n <\/font><\/td>\nNo Implied Representations<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.3<\/font><\/td>\n <\/font><\/td>\nKnowledge<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.4<\/font><\/td>\n <\/font><\/td>\nAccess of Seller to Books and Records<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.5<\/font><\/td>\n <\/font><\/td>\nGoverning Law<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.6<\/font><\/td>\n <\/font><\/td>\nVenue and Jurisdiction<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.7<\/font><\/td>\n <\/font><\/td>\nNotices<\/font><\/td>\n <\/font><\/td>\n18<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.8<\/font><\/td>\n <\/font><\/td>\nPublic Announcements<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.9<\/font><\/td>\n <\/font><\/td>\nAssignment<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.10<\/font><\/td>\n <\/font><\/td>\nParties in Interest<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.11<\/font><\/td>\n <\/font><\/td>\nSeverability<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.12<\/font><\/td>\n <\/font><\/td>\nEntire Agreement<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.13<\/font><\/td>\n <\/font><\/td>\nWaiver<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.14<\/font><\/td>\n <\/font><\/td>\nAmendments<\/font><\/td>\n <\/font><\/td>\n19<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.15<\/font><\/td>\n <\/font><\/td>\nCounterparts<\/font><\/td>\n <\/font><\/td>\n20<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.16<\/font><\/td>\n <\/font><\/td>\nInterpretation of Agreement<\/font><\/td>\n <\/font><\/td>\n20<\/font><\/td>\n<\/tr>\n
 <\/font><\/td>\n <\/font><\/td>\n10.17<\/font><\/td>\n <\/font><\/td>\nFurther Assurances<\/font><\/td>\n <\/font><\/td>\n20<\/font><\/td>\n<\/tr>\n<\/table>\n
ii<\/font><\/p>\n
\n
 <\/a><\/p>\n
TABLE OF EXHIBITS AND SCHEDULES  <\/b><\/font><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Exhibit A<\/font><\/td>\n <\/font><\/td>\nCertain Definitions<\/font><\/td>\n<\/tr>\n
Exhibit B<\/font><\/td>\n <\/font><\/td>\nForm of Assumption Agreement<\/font><\/td>\n<\/tr>\n
Exhibit C<\/font><\/td>\n <\/font><\/td>\nForm of Investor Rights Agreement<\/font><\/td>\n<\/tr>\n
Exhibit D<\/font><\/td>\n <\/font><\/td>\nForm of Employee Matters Agreement<\/font><\/td>\n<\/tr>\n
Exhibit E<\/font><\/td>\n <\/font><\/td>\nForm of Transition Services Agreement<\/font><\/td>\n<\/tr>\n
Exhibit F<\/font><\/td>\n <\/font><\/td>\nForm of Data Transfer and Professional Services Agreement<\/font><\/td>\n<\/tr>\n
Exhibit G<\/font><\/td>\n <\/font><\/td>\nForm of Nondisclosure Agreement<\/font><\/td>\n<\/tr>\n
Exhibit H<\/font><\/td>\n <\/font><\/td>\nForm of Manufacturing Agreement<\/font><\/td>\n<\/tr>\n
Exhibit I<\/font><\/td>\n <\/font><\/td>\nForm of License Agreement<\/font><\/td>\n<\/tr>\n
Exhibit J<\/font><\/td>\n <\/font><\/td>\nForm of Patent Assignment Agreement<\/font><\/td>\n<\/tr>\n
Exhibit K<\/font><\/td>\n <\/font><\/td>\nForm of NCS\/NX211 Sublicense Agreement<\/font><\/td>\n<\/tr>\n
Exhibit L<\/font><\/td>\n <\/font><\/td>\nForm of GSK\/NX211 Sublicense Agreement<\/font><\/td>\n<\/tr>\n
Exhibit M<\/font><\/td>\n <\/font><\/td>\nForm of GS7904L Sublicense Agreement<\/font><\/td>\n<\/tr>\n
Exhibit N<\/font><\/td>\n <\/font><\/td>\nForm of GS7836 Sublicense Agreement<\/font><\/td>\n<\/tr>\n

\nSchedule 1<\/font><\/td>\n
 <\/font><\/td>\n
\nCertain excluded assets<\/font><\/td>\n<\/tr>\n
Schedule 2<\/font><\/td>\n <\/font><\/td>\nContracts to be assigned<\/font><\/td>\n<\/tr>\n
Schedule 3<\/font><\/td>\n <\/font><\/td>\nPatents to be assigned<\/font><\/td>\n<\/tr>\n
Schedule 4<\/font><\/td>\n <\/font><\/td>\nKnow-how to be assigned<\/font><\/td>\n<\/tr>\n
Schedule 5<\/font><\/td>\n <\/font><\/td>\nRegulatory filings<\/font><\/td>\n<\/tr>\n
Schedule 6<\/font><\/td>\n <\/font><\/td>\nExcluded employees<\/font><\/td>\n<\/tr>\n
Schedule 7<\/font><\/td>\n <\/font><\/td>\nConsents to be obtained<\/font><\/td>\n<\/tr>\n
Schedule 8<\/font><\/td>\n <\/font><\/td>\nListed Available Employees<\/font><\/td>\n<\/tr>\n<\/table>\n
iii<\/font><\/p>\n
\n
 <\/a> <\/font><\/p>\n
 <\/a>
\n <\/a>
\n
<\/font>ASSET PURCHASE AGREEMENT    
  <\/b><\/font><\/p>\n
    <\/font>THIS ASSET PURCHASE AGREEMENT<\/b><\/font> is being entered into as of November 26, 2001, by and between: <\/font> GILEAD SCIENCES<\/b><\/font>,
\n<\/font>INC<\/b><\/font>., a Delaware corporation (“Seller”); and <\/font>OSI
\nPHARMACEUTICALS, INC<\/b><\/font>., a Delaware corporation (“Purchaser”). Seller and Purchaser are referred to collectively in this Agreement as the “Parties.” Certain other capitalized
\nterms used in this Agreement are defined in Exhibit A. <\/font><\/p>\n
RECITAL  <\/b><\/font><\/p>\n
    The Parties wish to provide for the purchase by Purchaser of certain assets from Seller, and to provide for certain related transactions, on the terms and
\nsubject to the conditions and other provisions set forth in this Agreement and in the Ancillary Agreements. <\/font><\/p>\n
AGREEMENT  <\/b><\/font><\/p>\n
    The Parties, intending to be legally bound, agree as follows: <\/font><\/p>\n
1.  SALE AND PURCHASE OF ASSETS; RELATED TRANSACTIONS.  <\/b><\/font><\/p>\n
    <\/font>1.1<\/b><\/font>  Sale and Purchase of Assets.<\/b><\/font>  On the terms and
\nsubject to the conditions and other provisions set forth in this Agreement and in the Ancillary Agreements, at the Closing, Seller will sell and transfer to Purchaser, and Purchaser will purchase from
\nSeller, all of the following (which, subject to Section 1.2, are referred to in this Agreement as the “Specified Assets”): <\/font><\/p>\n